Prescription drug · ANDA
Protamine Sulfate NDC 51662-1414
Protamine sulfate 10 mg/mL · Injection, Solution · Intravenous · HF Acquisition Co LLC, DBA HealthFirst
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51662-1414-1 | 51662141401 | 5 mL in 1 VIAL, SINGLE-DOSE (51662-1414-1)Marketed from Oct 13, 2019 | |
| 51662-1414-3 | 51662141403 | 25 POUCH in 1 CASE (51662-1414-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1414-2) / 5 mL in 1 VIAL, SINGLE-DOSEMarketed from Jun 16, 2023 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Protamine Sulfate
- Generic name (nonproprietary)
- protamine sulfate
- Active ingredients
- Protamine sulfate — 10 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 089454
- Marketing start
- Listing expires
- Other FDA classes
- Heparin Binding Activity (Mechanism)Reversed Anticoagulation Activity (Physiologic effect)
- Identifiers
- Product ID 51662-1414_0f90d77c-0de8-d2a3-e063-6394a90a067dSPL ID 0f90d77c-0de8-d2a3-e063-6394a90a067dSPL set ID 94d4f57f-940e-c0a8-e053-2a95a90ae3afRxCUI 1796672UNII 0DE9724IHCUPC 0363323229054
- Pharmacologic class
- Heparin Reversal Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N451662141401followed by a unit qualifier and the quantityPackage 51662-1414-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS & USAGE Protamine Sulfate Injection, USP is indicated in the treatment of heparin overdosage.
Excerpt only. Read the full label for complete information.
About NDC 51662-1414
- What is NDC 51662-1414?
- 51662-1414 is the product NDC for Protamine Sulfate, Protamine sulfate 10 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Protamine Sulfate.
- What is the active ingredient?
- Protamine sulfate.
- Who is the labeler?
- HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Protamine Sulfate?
- 4 other product NDCs are listed under this name. See all Protamine Sulfate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Protamine Sulfate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Protamine Sulfate | Protamine sulfate 10 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-646 | 65219-0646-05 |
| Protamine Sulfate | Protamine sulfate 10 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-229 | 63323-0229-9463323-0229-95 |
| Protamine Sulfate | Protamine sulfate 10 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-229 | 63323-0229-0563323-0229-30 |
| Protamine Sulfate | Protamine sulfate 10 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-229 | 63323-0229-1563323-0229-35 |
Other NDCs under ANDA 089454
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Protamine Sulfate | Protamine sulfate 10 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-229 |
| Protamine Sulfate | Protamine sulfate 10 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-229 |
| Protamine Sulfate | Protamine sulfate 10 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-229 |
| Protamine Sulfate | Protamine sulfate 10 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-646 |